BioSpace News Archive

Daiichi Sankyo Company, Ltd. (hereafter, Daiichi Sankyo) announced that the first patient has been dosed in a first-in-human phase 1 study assessing the safety and tolerability of DS-1205, a highly selective investigational AXL inhibitor, in combination with gefitinib in patients with metastatic or unresectable epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) who have progressed on therapy with tyrosine kinase inhibitors (TKIs).

Region’s Largest Retinal & Macular Practice To Add Doctors, Maryland Offices

Precision OT, a leading provider of optical transceivers and related active/passive optical components, announces the launch of its innovative, machine learning-powered software-defined networking (SDN) application designed to monitor and analyze the physical layer of an optical software-defined network.

The Green Organic Dutchman Holdings Ltd. is pleased to announce two strategic appointments within its leadership team, with Emily Demeo joining as Marketing Brand Director and Terry Reid joining as Director, Legal and Compliance.

Nutriband Inc. (OTCQB: NTRB), is pleased to announce the television broadcast of an exclusive interview of its CEO, Gareth Sheridan, and President, Sean Gallagher, on the weekly business television program - Worldwide Business with Kathy Ireland®.

Expands intellectual property to 30 issued patents globally for highly sensitive methods of detecting cancer biomarkers

Groundbreaking robotics research in the emerging area of human augmentation, which focuses on wearable exoskeletons to improve the performance of the human body, is featured in the October issue of the IEEE Transactions on Neural Systems and Rehabilitation Engineering (TNSRE),

Kolk will be responsible for Clinical Assay Development, Assay Integration and Clinical Trials.

Parents, healthcare professionals and students are invited to learn from world-renowned cord blood transplant doctors and researchers during World Cord Blood Day 2018 (November 15th) by attending the official online virtual conference (free event).

Among the findings, after 3 dIUI cycles, an Intravaginal culture (INVOcell) cycle appears to be a more cost-effective option for lesbian couples.